肾小球系膜细胞增殖抑制的研究进展

摘要/Abstract

摘要： 肾小球系膜细胞异常增殖对肾小球疾病进展有重要作用,探讨其发生机制对肾小球疾病的防治具有重要意义。本文综述了近年来肾小球系膜细胞增殖机制及抑制因子的研究进展。

Abstract: The abnormal proliferation of mesangial cells is important in the inflammation process and the development process of glomerular disease. It is of great significance to control glomerular disease to clarify the mechanism of proliferation. The article reviewed newly progress in the mechanism and inhibitor of mesangial cell proliferation.

Key words: Mesangial cell, Proliferation, Inhibitor

中图分类号:

R692.6

景贤, 王亚芹, 欧阳冬生. 肾小球系膜细胞增殖抑制的研究进展[J]. 中国临床药理学与治疗学, 2013, 18(6): 710-714.

JING Xian, WANG Ya-qin, OUYANG Dong-sheng. Study on the inhibition of glomerular mesangial cell proliferation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(6): 710-714.

参考文献

[1] Shen B, Zhu J, Zhang J, et al. Attenuated mesangial cell proliferation related to store-operated Ca(2+) entry in aged rat: the role of STIM 1 and Orai 1[J]. Age (Dordr), 2013,Epub ahead of print.
[2] Griffin SV, Pichler R, Dittrich M, et al. Cell cycle control in glomerular disease[J]. Springer Semin Immunopathol,2003, 24(4): 441-457.
[3] Su B, Chen X, Zhong C, et al. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1and p27Kip1 and down- regulating Skp2[J]. J Nephrol,2012, 25(6):1031-1040.
[4] Zou L, Wang W, Xu Z, et al. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells[J]. Int J Mol Med,2012, 30(2):409-416.
[5] Xue Y, Tie CR, Li J, et al. Ligustrazine inhibits lipopolysaccharide - induced proliferation by affecting P27, Bcl-2 expression in rat mesangial cells[J]. Eur J Pharmacol,2011, 665(1/2/3):8-12.
[6] 汪霞, 黎七雄. 川芎嗪对脂多糖诱导大鼠肾小球系膜细胞增殖及细胞问粘附因子-1表达的影响[J]. 中国临床药理学与治疗学,2004, 9(4):420-422.
[7] 肖建武, 易著文, 吴小川. 川芎嗪注射液对大鼠肾小球系膜细胞增生的影响[J]. 医药导报, 2004, 23(9):611-613.
[8] Jiang J, Huang X, Wang Y, et al. FTY720 induces cell cycle arrest and apoptosis of rat glomerular mesangial cells[J]. Mol Biol Rep, 2012, 39 (8):8243-8250.
[9] Yuan P, Xue H, Zhou L, et al. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide[J]. Nephrol Dial Transplant,2011, 26(7): 2119-2126.
[10]Paccosi S, Musilli C, Mangano G, et al. The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling[J]. Pharmacol Res, 2012, 66 (6):526- 535.
[11]Hirasawa Y, Sakai T, Ito M, et al. Advanced-glycation-end- product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta1 receptors and the ERK-MAPK pathway[J]. Eur J Pharmacol,2011, 672 (1/2/ 3):159-168.
[12]Li W, Cui M, Wei Y,et al. Inhibition of the expression of tgf-β1 and ctgf in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist[J]. Cell Physiol Biochem,2012, 30 (3):749-757.
[13]Loeffler I, Hopfer U, Koczan D, et al. Type VIII collagen modulates TGF-β₁-induced proliferation of mesangial cells[J]. J Am Soc Nephrol, 2011, 22 (4):649-663.
[14]Davenport AP, Maguire JJ. Pharmacology of renal endothelin receptors[J]. Contrib Nephrol,2011, 172:1-17.
[15]Wang R, Wan Q, Zhang Y, et al. Emodin suppresses interleukin-1β induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK[J]. Life Sciences,2007, 80(26): 2481-2488.
[16]Lu H, Zhou J. HBV X gene transfection upregulates IL-1beta and IL-6 gene expression and induces rat glomerular mesangial cell proliferation[J]. J Huazhong Univ Sci Technolog Med Sci,2008, 28(3):247-250.
[17]Robertson TE, Nikolic-Paterson DJ, Hurst LA, et al. IL-10 induces mesangial cell proliferation via a PDGF-dependent mechanism[J]. Clin Exp Immunol, 2002, 130(2): 241-244.
[18]Kalechman Y, Gafter U, Weinstein T, et al. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3 [J]. J Biol Chem,2004, 279(23):24724-24732.
[19]Wang H, Yin Y, Li W, et al. Over-expression of PDGFR-β promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway [J]. PLoS One,2012, 7(2):e30503.
[20]Woo KT, Lau YK. Proteinuria: clinical signficance and basis for therapy[J]. Singapore Med J,2001, 42(8):385-389.
[21]Singh R, Leehey DJ. Effect of ACE inhibitors on angiotensin II in rat mesangial cells cultured in high glucose[J]. Biochem Biophys Res Commun,2007, 357(4):1040-1045.
[22]Qiu G, Ji Z. AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration[J]. Clin Exp Med,2013,Epub ahead of print.
[23]Robles NR. Calcium antagonists and renal failure progression[J]. Ren Fail,2008, 30(3):247-255.
[24]Yasuhisa K. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease[J]. Med Res Rev, 2003, 23(1):15-31.
[25]Mulgrew CJ, Cove-Smith A, McLatchie LM, et al. Inhibition of human mesangial cell proliferation by targeting T-type calcium channels[J]. Nephron Exp Nephrol,2009, 113(2):e77-88.
[26]Bokemeyer D, Panek D, Kitahara M, et al. The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis [J]. Nephrol Dial Transplant, 2007, 22(12):3431-3441.
[27]Wang B, Zhang A, Zheng J, et al. Gong J Bufalin inhibits platelet-derived growth factor-BB-induced mesangial cell proliferation through mediating cell cycle progression[J]. Biol Pharm Bull,2011, 34(7):967-973.
[28]Danilewicz M, Wagrowska-Danilewicz M. Differential glomerular immuno- expression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis[J]. Folia Histochem Cytobiol,2010, 48(1):63-67.
[29]Daniel C, Duffield J, Brunner T, et al. Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells[J]. J Pharmacol Exp Ther,2001, 297(1):57-68.
[30]Wang W, Chan YH, Lee W, et al. Effect of rapamycin and FK506 on mesangial cell proliferation[J]. Transplant Proc,2001, 33(1/2):1036-1037.
[31]Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy[J]. Proc Natl Acad Sci USA,2002, 99(12):8301-8305.
[32]Zou L, Wang W, Xu Z, et al. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells[J]. Int J Mol Med, 2012, 30(2):409-416.
[33]Su YX, Deng HC, Zhang MX, et al. Adiponectin inhibits PDGF-induced mesangial cell proliferation: regulation of mammalian target of rapamycin-mediated survival pathway by adenosine 5-monophosphate-activated protein kinase[J]. Horm Metab Res,2012, 44(1):21-27.
[34]Cobanolu B, Toskala E, Ural A, et al. Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis[J]. Curr Allergy Asthma Rep,2013, 13(2):203-208.
[35]Park J, Song KH, Ha H. Fractalkine increases mesangial cell proliferation through reactive xxygen species and mitogen-activated protein kinases[J]. Transplant Proc,2012, 44(4):1026-1028.
[36]Dubey RK, Jackson EK. Estrogen induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms[J]. Am J Physiol Renal Physiol,2001, 280 (3):F365-388.
[37]Xiao S, Gillespie DG, Baylis C, et al. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth[J]. Hypertension,2001, 37(2 part 2):645-650.
[38]Dubey RK, Gillespie DG, Keller PJ, et al. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells[J]. Hypertension,2002, 39(2 part 2):418-424.
[39]Dubey RK, Zacharia LC, Gillespie DG, et al. Catecholamines block the antimitogenic effect of estradiol on human glomerular mesangial cells[J]. Hypertension,2003, 42(3):349-355.
[40]Song L, Xiao W, Templeton DM. Low-concentra-tion heparin suppresses ionomycin-activated CAMK-II/EGF receptor-and ERK-mediated signaling in mesangial cells[J]. J Cell Physiol,2010, 224(2):484-490.